These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 33341662

  • 1. Effects of acid and lactone forms of statins on S-warfarin 7-hydroxylation catalyzed by human liver microsomes and recombinant CYP2C9 variants (CYP2C9.1 and CYP2C9.3).
    Shiozawa A, Yamaori S, Kamijo S, Ohmori S.
    Drug Metab Pharmacokinet; 2021 Feb; 36():100364. PubMed ID: 33341662
    [Abstract] [Full Text] [Related]

  • 2. In vitro inhibition of CYP2C9-mediated warfarin 7-hydroxylation by iguratimod: possible mechanism of iguratimod-warfarin interaction.
    Yamaori S, Takami K, Shiozawa A, Sakuyama K, Matsuzawa N, Ohmori S.
    Biol Pharm Bull; 2015 Feb; 38(3):441-7. PubMed ID: 25757926
    [Abstract] [Full Text] [Related]

  • 3. Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport.
    Sakaeda T, Fujino H, Komoto C, Kakumoto M, Jin JS, Iwaki K, Nishiguchi K, Nakamura T, Okamura N, Okumura K.
    Pharm Res; 2006 Mar; 23(3):506-12. PubMed ID: 16388406
    [Abstract] [Full Text] [Related]

  • 4. Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins.
    Filppula AM, Hirvensalo P, Parviainen H, Ivaska VE, Lönnberg KI, Deng F, Viinamäki J, Kurkela M, Neuvonen M, Niemi M.
    Drug Metab Dispos; 2021 Aug; 49(8):658-667. PubMed ID: 34045219
    [Abstract] [Full Text] [Related]

  • 5. Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity.
    Yamaori S, Koeda K, Kushihara M, Hada Y, Yamamoto I, Watanabe K.
    Drug Metab Pharmacokinet; 2012 Aug; 27(3):294-300. PubMed ID: 22166891
    [Abstract] [Full Text] [Related]

  • 6. In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors.
    Transon C, Leemann T, Dayer P.
    Eur J Clin Pharmacol; 1996 Aug; 50(3):209-15. PubMed ID: 8737761
    [Abstract] [Full Text] [Related]

  • 7. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
    Brantley SJ, Oberlies NH, Kroll DJ, Paine MF.
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization.
    Prueksaritanont T, Subramanian R, Fang X, Ma B, Qiu Y, Lin JH, Pearson PG, Baillie TA.
    Drug Metab Dispos; 2002 May; 30(5):505-12. PubMed ID: 11950779
    [Abstract] [Full Text] [Related]

  • 13. Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.
    Zhang N, Seguin RP, Kunze KL, Zhang YY, Jeong H.
    Drug Metab Dispos; 2013 Dec; 41(12):2114-23. PubMed ID: 24046330
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.
    Neuvonen PJ, Backman JT, Niemi M.
    Clin Pharmacokinet; 2008 Dec; 47(7):463-74. PubMed ID: 18563955
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of sesamin on CYP2C9-dependent 7-hydroxylation of S-warfarin.
    Fujii M, Yasuda K, Sakaki T.
    Drug Metab Pharmacokinet; 2020 Aug; 35(4):368-373. PubMed ID: 32601017
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of Drug-Drug Interactions Between Warfarin and Statins.
    Shaik AN, Bohnert T, Williams DA, Gan LL, LeDuc BW.
    J Pharm Sci; 2016 Jun; 105(6):1976-1986. PubMed ID: 27103011
    [Abstract] [Full Text] [Related]

  • 17. Effect of glimepiride and glibenclamide on S-warfarin 7-hydroxylation by human liver microsomes, recombinant human CYP2C9.1 and CYP2C9.3.
    Iwakawa S, Miyashita K, Hashimoto Y, Kuroda T.
    Biol Pharm Bull; 2006 Sep; 29(9):1983-5. PubMed ID: 16946524
    [Abstract] [Full Text] [Related]

  • 18. Warfarin analog inhibition of human CYP2C9-catalyzed S-warfarin 7-hydroxylation.
    Zhang ZY, Kerr J, Wexler RS, Li HY, Robinson AJ, Harlow PP, Kaminsky LS.
    Thromb Res; 1997 Nov 15; 88(4):389-98. PubMed ID: 9526963
    [Abstract] [Full Text] [Related]

  • 19. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
    Yamazaki H, Shimada T.
    Arch Biochem Biophys; 1997 Oct 01; 346(1):161-9. PubMed ID: 9328296
    [Abstract] [Full Text] [Related]

  • 20. Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8.
    Tornio A, Pasanen MK, Laitila J, Neuvonen PJ, Backman JT.
    Basic Clin Pharmacol Toxicol; 2005 Aug 01; 97(2):104-8. PubMed ID: 15998357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.